Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Pharmaceutical Preparations · market cap $154.0B · as of 2026-06-23
Research and calibrated estimates, not financial advice — verify before acting.
| Asset | Phase | Indication |
|---|---|---|
| ABT-712 | Phase 3 | Chronic Low Back Pain |
| Acetaminophen | Phase 2 | Pain |
| Zemplar Capsule | Phase 3 | Kidney Disease |
| ABT-263 | Phase 2 | Small Cell Lung Cancer |
| Carboplatin | Phase 2 | Non-Small -Cell Lung Cancer |
| rosuvastatin calcium | Phase 3 | Mixed Dyslipidemia |
| Maxacalcitol | Phase 3 | Chronic Kidney Disease on Hemodialysis |
| ABT-639 | Phase 2 | Diabetic Neuropathic Pain |
| Hydrocodone/Acetaminophen on Extended Release | Phase 3 | Moderate to Severe Chronic, Non-malignant Pain |
| ABT-126 | Phase 2 | Cognitive Deficits in Schizophrenia |
| Extended-Release Hydrocodone/Acetaminophen | Phase 2 | Pain |
| Ribavirin | Phase 3 | Chronic Hepatitis C Infection |
| 0.25 mg Atrasentan QD | Phase 2 | Chronic Kidney Disease |
| DB adalimumab 40 mg eow | Phase 3 | Crohn's Disease |
| Clarithromycin | Phase 3 | Acute Bacterial Sinusitis (ABS) |
| adalimumab (Humira) | Phase 3 | Ankylosing Spondylitis |
| Cell-Derived Trivalent Subunit Influenza Vaccine | Phase 2 | Influenza |
| oxaliplatin | Phase 2 | Advanced Colorectal Cancer |
| temozolomide | Phase 2 | Melanoma |
| Mitizax | Phase 3 | Allergy |
The full dossier is a Pro feature
Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by Celia. The catalyst path & pipeline above are free.
See ProData from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, Financial Modeling Prep). Compiled by Celia. Not financial advice.